BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25557669)

  • 1. Pharmaceuticals in the environment: expected and unexpected effects on aquatic fauna.
    Fabbri E
    Ann N Y Acad Sci; 2015 Mar; 1340():20-8. PubMed ID: 25557669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted critical environmental concentrations for 500 pharmaceuticals.
    Fick J; Lindberg RH; Tysklind M; Larsson DG
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):516-23. PubMed ID: 20816909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.
    Donnachie RL; Johnson AC; Sumpter JP
    Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
    Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
    J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species.
    Fabbri E; Franzellitti S
    Environ Toxicol Chem; 2016 Apr; 35(4):799-812. PubMed ID: 26111460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
    Mezzelani M; Gorbi S; Regoli F
    Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and depuration of pharmaceuticals in aquatic invertebrates.
    Meredith-Williams M; Carter LJ; Fussell R; Raffaelli D; Ashauer R; Boxall AB
    Environ Pollut; 2012 Jun; 165():250-8. PubMed ID: 22226124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk screening of pharmaceutical compounds in Romanian aquatic environment.
    Gheorghe S; Petre J; Lucaciu I; Stoica C; Nita-Lazar M
    Environ Monit Assess; 2016 Jun; 188(6):379. PubMed ID: 27234514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratogenicity and embryotoxicity in aquatic organisms after pesticide exposure and the role of oxidative stress.
    Pašková V; Hilscherová K; Bláha L
    Rev Environ Contam Toxicol; 2011; 211():25-61. PubMed ID: 21287390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmaceuticals present in aquatic environment on Phase I metabolism in fish.
    Burkina V; Zlabek V; Zamaratskaia G
    Environ Toxicol Pharmacol; 2015 Sep; 40(2):430-44. PubMed ID: 26278678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respective contributions of diet and medium to the bioaccumulation of pharmaceutical compounds in the first levels of an aquatic trophic web.
    Orias F; Simon L; Perrodin Y
    Environ Sci Pollut Res Int; 2015 Dec; 22(24):20207-14. PubMed ID: 26304809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the pharmaceutical exposome in aquatic fauna.
    Miller TH; Bury NR; Owen SF; MacRae JI; Barron LP
    Environ Pollut; 2018 Aug; 239():129-146. PubMed ID: 29653304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of pharmaceuticals in benthic fauna living in a small stream affected by effluent from a municipal sewage treatment plant.
    Grabicova K; Grabic R; Blaha M; Kumar V; Cerveny D; Fedorova G; Randak T
    Water Res; 2015 Apr; 72():145-53. PubMed ID: 25283339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
    Huerta B; Rodríguez-Mozaz S; Barceló D
    Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging challenges of the impacts of pharmaceuticals on aquatic ecosystems: A diatom perspective.
    Kock A; Glanville HC; Law AC; Stanton T; Carter LJ; Taylor JC
    Sci Total Environ; 2023 Jun; 878():162939. PubMed ID: 36934940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mode of action (MOA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis.
    Franzellitti S; Buratti S; Valbonesi P; Fabbri E
    Aquat Toxicol; 2013 Sep; 140-141():249-56. PubMed ID: 23831970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing lethal and sub-lethal effects of trichlorfon on different trophic levels.
    Coelho S; Oliveira R; Pereira S; Musso C; Domingues I; Bhujel RC; Soares AM; Nogueira AJ
    Aquat Toxicol; 2011 Jun; 103(3-4):191-8. PubMed ID: 21473847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure and ecotoxicological risk assessment of mixtures of top prescribed pharmaceuticals in Swedish freshwaters.
    Lindim C; de Zwart D; Cousins IT; Kutsarova S; Kühne R; Schüürmann G
    Chemosphere; 2019 Apr; 220():344-352. PubMed ID: 30590300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating exposure into aquatic toxicological studies: an imperative.
    Wang WX
    Aquat Toxicol; 2011 Oct; 105(3-4 Suppl):9-15. PubMed ID: 22099340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.